AREDS2 Formula Continues Benefitting AMD in Certain Late Stage Patients: NIH Analysis

The findings support continued use of the supplement formula into later stages of age-related macular degeneration than previously studied.

​The findings support continued use of the supplement formula into later stages of age-related macular degeneration than previously studied. Read More

Related posts:

NIH-Funded Study Concludes Multivitamin Use Not Associated with Reduced Mortality Doctor’s Best Launches Vegan Omega-3 Supplement MegaFood Launches Plant-based Omega 3-6-9 Supplement EpiCor Postbiotic Gummy Supplement Shown to Support Children’s Immune Health US FDA confirms Arla Foods Ingredients whey protein hydrolysates can be used in infant formula Standard Process Launches Mushroom Complex for Cats and Dogs